Search results for "macula"

showing 10 items of 345 documents

La historia cultural de las imágenes. : Una propuesta metodológica en la Universitat Jaume I, aplicada al arte de la Edad Moderna

2012

UNESCO::CIENCIAS DE LAS ARTES Y LAS LETRASVíctor:CIENCIAS DE LAS ARTES Y LAS LETRAS [UNESCO]aplicada al arte de la Edad Moderna Mínguez CornellesRodríguez Moya0211-5808 9678 Archivo de arte valenciano 324818 2012 93 4182062 La historia cultural de las imágenes. Una propuesta metodológica en la Universitat Jaume IInmaculada 175 194
researchProduct

Evaluación de la función visual en pacientes con degeneración macular asociada a la edad avanzada de tipo atrófico

2020

Objetivo:El presente trabajo pretende integrar la evaluación anatómica tomografía de coherencia óptica (OCT) y la autofluorescencia del fondo de ojo (FAF) con la evaluación funcional exhaustiva incluyendo la agudeza visual (AV) en visión lejana y próxima, la velocidad lectora, la agudeza visual en baja iluminación (LLVA), la función de sensibilidad al contracte (CSF), la microperimetría macular y el test de calidad de vida relacionado con la visión, con la finalidad de establecer un protocolo de pruebas indispensables para el seguimiento y valoración de esta patología. Pacientes y métodos: Sesenta y tres ojos de 63 sujetos ≥ 50 años fueron reclutados para el estudio observacional; 31 sujeto…

UNESCO::FÍSICA::Óptica:FÍSICA::Óptica [UNESCO]función visualcalidad de vidadegeneración macular asociada a la edadcalidad visualatrofia geográfica
researchProduct

Real-life patient journey in neovascular age-related macular degeneration: a narrative medicine analysis in the Italian setting

2021

Objectives To investigate the real-life experience of patients affected by neovascular age-related macular degeneration (nAMD), in the healthcare pathway for the management of the disease, using a "patient journey" and narrative method approach. Methods The patient journey of subjects affected by nAMD was designed using a process-mapping methodology involving a team from 11 Italian centres. Subsequently, narratives were collected from nAMD patients and family members. The interviews were analyzed using the narrative medicine methodology. Results Eleven specialized retina centres across Italy were involved and 205 narratives collected. In 29% of cases, patients underestimated their symptoms …

Vascular Endothelial Growth Factor Amedicine.medical_specialtyActivities of daily livingage related macular degenerationMEDLINEAngiogenesis InhibitorsDiseaseArticle03 medical and health sciencesMacular Degeneration0302 clinical medicineMultidisciplinary approachRanibizumabHealth carereal lifeMedicinepatient journeyHumansNarrativeeducationNarrative medicineeducation.field_of_studyNarrative medicine wet AMDbusiness.industrySettore MED/30 - Malattie Apparato VisivoNarrative MedicineMacular degenerationmedicine.diseaseOphthalmologyFamily medicineIntravitreal Injections030221 ophthalmology & optometryQuality of LifeWet Macular Degenerationbusiness030217 neurology & neurosurgery
researchProduct

Risk of Death Associated With Intravitreal Anti-Vascular Endothelial Growth Factor Therapy: A Systematic Review and Meta-analysis.

2020

Importance Although intravitreal anti–vascular endothelial growth factor (VEGF) treatment represents the first-line therapy for many retinal diseases, the issue of their systemic safety is debatable. Objectives To assess whether intravitreal anti-VEGF therapy might be associated with increased risk of mortality and which variables are associated with the increase. Data Sources PubMed, MEDLINE, and Embase databases, the Cochrane Library, and ClinicalTrials.gov were systematically searched from inception to May 6, 2019. Study Selection Randomized clinical trials comparing intravitreal anti-VEGF treatment with control groups and with follow-up of at least 6 months were selected. Data Extractio…

Vascular Endothelial Growth Factor Amedicine.medical_specialtyDatabases FactualMEDLINEAngiogenesis InhibitorsCochrane LibraryMacular Edemalaw.inventionRandomized controlled triallawFrequentist inferenceInternal medicineCause of DeathRetinal Vein OcclusionMedicineHumansanti-VEGF therapyrisk of mortality anti-vascular endothelial growth factor mortalityCause of deathOriginal InvestigationRandomized Controlled Trials as TopicDiabetic Retinopathybusiness.industryMortality rateOdds ratioChoroidal NeovascularizationOphthalmologyMeta-analysisIntravitreal InjectionsWet Macular DegenerationbusinessJAMA ophthalmology
researchProduct

Intravitreal dexamethasone implant versus anti-vascular endothelial growth factor therapy combined with cataract surgery in patients with diabetic ma…

2021

Objective: to compare outcomes of cataract surgery combined with either anti-Vascular Endothelial Growth Factor (anti-VEGF) therapy or dexamethasone implant (DEX) in patients with diabetic macular oedema (DMO). Methods: Pubmed and Embase databases were searched for studies reporting outcomes of diabetic cataract surgery combined with either anti-VEGF or DEX, with a follow-up ≥3 months. The primary outcome was the mean change in central macular thickness (CMT). Mean change in best corrected visual acuity (BCVA) was considered as a secondary outcome. The mean difference between baseline and post-treatment values (MD) with 95%-Confidence Interval (95%CI) was calculated and meta-analyses were p…

Vascular Endothelial Growth Factor Amedicine.medical_specialtygenetic structuresmedicine.medical_treatmentVisual AcuityEndothelial Growth FactorsMacular EdemaDexamethasoneCataractOphthalmologyDiabetes MellitusHumansMedicineIn patientDexamethasoneDiabetic Retinopathybusiness.industryDEXcataract surgeryCataract surgeryDiabetic cataractBevacizumabOphthalmologyAnti–vascular endothelial growth factor therapyDiabetic macular oedemaanti-VEGFdiabetic macular oedemaMeta-analysissense organsImplantbusinessmedicine.drugEye
researchProduct

Treat and extend versus fixed regimen in neovascular age related macular degeneration: A systematic review and meta-analysis

2020

Purpose: To compare efficacy of treat and extend (T&E) versus fixed regimen treatment protocols in neovascular age-related macular degeneration (nAMD). Methods: Randomized clinical trials (RCTs) comparing T&E versus fixed regimen protocols for nAMD were systematically searched. Primary outcome was to compare the mean best corrected visual acuity (BCVA) change in T&E regimen versus fixed regimen. Secondary outcomes were change in the mean optical coherence tomography (OCT) central retinal thickness (CRT) and mean number of injections. Standardized mean difference (SMD) along with 95% confidence intervals (CIs) were calculated. Random-effect models were used for meta-analyses. Res…

Vascular Endothelial Growth Factor Amedicine.medical_specialtyretinaretinal pathology/researchVisual AcuityAngiogenesis InhibitorsTreat and extendlaw.inventionMacular DegenerationRandomized controlled trialClinical Protocolsretina – medical therapieslawInternal medicineAge relatedRanibizumabMedicineHumansbusiness.industryAge-related macular degenerationGeneral MedicineMacular degenerationpediatric ophthalmologyretina – medical therapiemedicine.diseaseOphthalmologyRegimenTreatment OutcomeMeta-analysisvitreous/retinal diseaseIntravitreal InjectionsWet Macular DegenerationPediatric ophthalmologypharmacologybusinessTomography Optical CoherenceAge-related macular degeneration; pediatric ophthalmology; pharmacology; retina; retina – medical therapies; retinal pathology/research; vitreous/retinal disease
researchProduct

Early OCTA Changes of Type 3 Macular Neovascularization Following Brolucizumab Intravitreal Injections

2022

Background and Objectives: Brolucizumab is a novel anti-vascular endothelial growth factor (VEGF), whose efficacy has been shown in the Hawk and Harrier phase 3 clinical studies. The goal of the present case series is to report initial results of brolucizumab intravitreal injections (IVI) on type 3 neovascularization in neovascular age-related macular degeneration (nAMD), evaluated by optical coherence tomography angiography (OCTA). Materials and Methods: This is a bicentric retrospective case series. Patients with newly diagnosed type 3 MNV treated with brolucizumab IVI and at least 6 months follow-up were enrolled. OCTA en face images and B-scans were analyzed for lesions at baseline, 1 m…

Vascular Endothelial Growth Factor Atype 3 neovascularization.brolucizumabNeovascularization PathologicVisual Acuityneovascular age-related macular degeneration; type 3 neovascularization; retinal angiomatous proliferation; brolucizumab; optical coherence tomography angiography; intravitreal injectionintravitreal injectionretinal angiomatous proliferationEndothelial Growth Factorsneovascular age-related macular degenerationGeneral MedicineAntibodies Monoclonal Humanizedoptical coherence tomography angiographyIntravitreal InjectionsHumansFluorescein AngiographyTomography Optical CoherenceRetrospective StudiesMedicina
researchProduct

Classification of diabetes-related retinal diseases using a deep learning approach in optical coherence tomography

2019

Background and objectives: Spectral Domain Optical Coherence Tomography (SD-OCT) is a volumetric imaging technique that allows measuring patterns between layers such as small amounts of fluid. Since 2012, automatic medical image analysis performance has steadily increased through the use of deep learning models that automatically learn relevant features for specific tasks, instead of designing visual features manually. Nevertheless, providing insights and interpretation of the predictions made by the model is still a challenge. This paper describes a deep learning model able to detect medically interpretable information in relevant images from a volume to classify diabetes-related retinal d…

Volumetric imagingComputer scienceProfundo InterpretabilidadConvolutional neural network030218 nuclear medicine & medical imagingPattern Recognition Automatedchemistry.chemical_compoundMacular Degeneration[SPI]Engineering Sciences [physics]0302 clinical medicineDeep learning modelsInterpretabilityModelos de aprendizajeAged 80 and overArtificial neural networkmedicine.diagnostic_testMedical findings KeyWords Plus:MACULAR DEGENERATIONAngiographyMiddle AgedRetinal diseases3. Good healthComputer Science ApplicationsArea Under CurveTomographyMedical findingsAlgorithmsTomography Optical CoherenceAprendizaje - ModelosDiabetic macular edemaHealth InformaticsHallazgos médicosMacular Edema03 medical and health sciencesDeep LearningOptical coherence tomographymedicine[INFO.INFO-IM]Computer Science [cs]/Medical ImagingDeep InterpretabilityHumans[INFO]Computer Science [cs]Enfermedades de la retinaRetinopathyAgedDiabetic RetinopathyOptical coherence tomographybusiness.industryDeep learningReproducibility of ResultsRetinalPattern recognitionMacular degenerationmedicine.diseasechemistryArtificial intelligenceNeural Networks ComputerLa tomografía de coherencia ópticabusinessClassifier (UML)030217 neurology & neurosurgerySoftware
researchProduct

Proteomic analysis of sub-retinal deposits in age-related macular degeneration

2014

National audience

[SDE] Environmental Sciencesretina[SPI.GPROC] Engineering Sciences [physics]/Chemical and Process Engineering[SDV]Life Sciences [q-bio]aging[SDV.IDA] Life Sciences [q-bio]/Food engineering[SDV] Life Sciences [q-bio][SDE]Environmental Sciences[SDV.IDA]Life Sciences [q-bio]/Food engineering[SDV.BV]Life Sciences [q-bio]/Vegetal Biology[SPI.GPROC]Engineering Sciences [physics]/Chemical and Process Engineering[SDV.BV] Life Sciences [q-bio]/Vegetal Biologylaser dissection microscopeage-related macular degenerationComputingMilieux_MISCELLANEOUS
researchProduct

Des données cliniques à la vie réelle : quelles preuves pour le devenir des patients DMLA ?

2016

[SDV.AEN] Life Sciences [q-bio]/Food and Nutrition[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyDMLADégénérescence Maculaire Liée à l’Age
researchProduct